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We examined the effects of hemicellulase-treated Agaricus blazei (AB fraction H, ABH) on growth of
several tumor cell lines. ABH inhibited the proliferation of some cell lines without cytotoxic effects. It
markedly prolonged the S phase of the cell cycle. ABH also induced mitochondria-mediated apoptosis in
different cell lines. However, it had no impact on the growth of other cell lines. ABH induced strong
activation of p38 mitogen-activated protein kinase (MAPK) in the cells in which it evoked apoptosis. On
the other hand, ABH showed only a weak p38 activation effect in those cell lines in which it delayed cell
cycle progression with little induction of apoptosis. However, p38 MAPK-specific inhibitor inhibited
both ABH-induced effects, and ABH also caused apoptosis in the latter cells under conditions of high
p38 MAPK activity induced by combined treatment with TNF-a. These results indicate that the
responsiveness of p38 MAPK to ABH, which differs between cell lines, determines subsequent cellular
responses on cell growth.
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Introduction
Agaricus blazei Murill is a mushroom native to Brazil.
This mushroom grows naturally near Piedade, a coastal
Brazilian village, and it was eaten as a common food in this
area. As the local people had lower than average frequencies of
cancer and other age-related disorders, this basidiomycete has
attracted attention due to the possibility that it may contain
ingredients with beneficial health effects. There have been
numerous studies regarding its activities both in vitro and
in animal experiments. With regard to its anti-neoplastic
activity, the features of A. blazei can be classified into three
categories: immunomodulatory effects, such as activation of
macrophages and NK cells (1–6); protective effects against
genetic damage (7–12); and inhibitory effects on tumor cell
growth, cell migration or tumor-induced neovascularization
(3,13–15). Products derived from A. blazei have been
consumed by many patients with cancer believing them to
have medicinal properties in Japan (16). However, little is
known about its effects on humans. These products are used
mostly under self rather than medical supervision. There is no
clear medical justification for their use against cancer.
Recently, their exaggerated effectiveness in humans, which is
not supported by scientific evidence, has been widely
advertised. In addition, cases of health hazards during their
use have also been reported, although no causal relationships
have yet been demonstrated between these products and
deleterious effects on health. We doubt that these products
live up to their touted roles as veritable panaceas against
cancer. Furthermore, it is necessary to also determine the
influences of their use on the effects of existing cancer
treatments. Our previous study demonstrated bipartite char-
acteristics of A. blazei extract in that it induced the maturation
of murine bone marrow-derived dendritic cells and resulted
in a Th1-biased response in vitro, but it also inhibited some
responses induced by Toll-like receptor-mediated signaling,
such as production of pro-inflammatory cytokines (17).
A. blazei appears to have multiple biological activities.
In the present study, we examined the direct effects of
A. blazei extract on growth of several tumor cell lines to
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effectiveness. As it is difficult to abstract an essence from A.
blazei due to its low aqueous solubility, A. blazeiused here was
digested with hemicellulases to achieve solubility in water.
Hemicellulase-treated A. blazei (AB fraction H, ABH)
showed a strong antiproliferative effect, and induced p38
mitogen-activated protein kinase (MAPK)-mediated cell
growth delay and apoptosis in some cell lines. However,
ABH did not have the same effect on growth of all cell lines. It
had no effect on p38 MAPK activation in ABH-insensitive
cells. These results suggested that cellular factors, which
regulate p38 MAPK activation, hold the key to the suscept-
ibility of cells to the effects of ABH on proliferation.
Furthermore, as ABH induces a delay in cell cycle progression
in S phase in sensitive cells, it may also have an influence
on the therapeutic benefits of existing treatments against
cancer.
Methods
Cell Lines
The cell lines used here were as follows: BALL-1 (B cell
leukemia), CCRF-CEM (acute T lymphoblastic leukemia),
Jurkat (T cell leukemia), THP-1 (monocytic leukemia), U937
(histiocytic lymphoma), HeLa (uterine cervical carcinoma),
HMV-1 (melanoma), MCF7 (breast adenocarcinoma), sup-
plied by the Cell Resource Center for Biochemical Research,
Institute of Development, Aging and Cancer, Tohoku Univer-
sity (Sendai, Japan). Mycoplasma detection assay confirmed
all cell lines to be mycoplasma-negative (MycoAlert ;
Cambrex, Rockland, ME). The cells were maintained in
RPMI 1640 medium (for non-adherent cells) or Dulbecco’s
modified Eagle’s medium (for adherent cells) supplemented
with 10% heat-inactivated fetal bovine serum (HyClone,
Logan, UT).
Materials
The following antibodies were used in this study: anti-
cytochrome c mAb (Lab Vision Corporation, Fremont, CA),
anti-phospho-p38 MAPK (Thr180/Tyr182) mAb (Cell Signal-
ing Technology Inc., Danvers, MA), and fluorescein
isothiocyanate-conjugated anti-human TNF cell surface recep-
tor 1 (TNFR1) mAb (R&D Systems Inc., Minneapolis, MN).
Recombinant human TNF-a was purchased from PeproTech
Inc. (Rocky Hill, NJ). SB203580, SP600125 and PD98059
were obtained from EMD Biosciences, Inc. (Darmstadt,
Germany). These are specific inhibitors of p38 MAPK, c-Jun
N-terminal kinase (JNK) and MAPK extracellular signaling-
regulated kinase (ERK) kinase (MEK), respectively.
Hemicellulase-Treated A. blazei
Hemicellulase-treated A. blazei (AB fraction H, ABH) was
supplied by Japan Applied Microbiology Research Institute
Ltd (Yamanashi, Japan). Mycelia of A. blazei Murill were
digested with 0.1% hemicellulases from Trichoderma viride,
Trichoderma harzianum, Aspergillus tamari and Aspergillus
niger for 1 h at 45 C. After inactivation of the enzymes at
70 C, the filtrate of the degradation product was lyophilized.
ABH consists of 63.3% carbohydrates, 30.9% proteins, 0.3%
lipids and minor components. The samples were examined for
endotoxin by limulus amebocyte lysate (LAL) assay (Seika-
gaku Corp., Tokyo, Japan). The endotoxin contents of samples
were <0.02 EU per 1 mg of sample. The culture medium
containing 0.1% ABH had a pH of 7.1–7.4 and iso-osmotic
pressure (285 mOsm l
 1), determined by the freezing point
depression method (Auto & Stat OM-6030; ARKRAY Inc.,
Kyoto, Japan). For comparison with ABH, mycelia of A. blazei
Murill (Japan Applied Microbiology Research Institute
Ltd) were water-extracted without hemicellulase. After heat
treatment, the extract was lyophilized as described above.
Cell Growth and Viability
Cell growth was assessed by formazan formation induced by
reduction of exogenous tetrazolium salt. Cells (1 · 10
4per well
for non-adherent cells or 4 · 10
5 per well for adherent cells)
were cultured in flat-bottomed 96-well plates (BD Bios-
ciences, San Jose, CA). After incubation for the indicated
times, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium monosodium salt and 1-
methoxy-5-methylphenazinium methylsulfate mixture (Tetra-
Color ONE ; Seikagaku Corp., Tokyo, Japan) was added to
eachwell.Theopticaldensity wasmeasuredat450and630nm
(MolecularDevicesCorp.,Sunnyvale,CA)after2h.Inanother
experiment, non-adherent cells (2 to 4 · 10
5 per well) were
cultured in 24-well plates (BD Biosciences). The viable cell
number in the cultures was counted by trypan blue dye
exclusion method at the indicated times. The viability was
determined as percentage of trypan blue-negative cells to
total cells.
Apoptosis
Apoptosis was assessed by determining phosphatidylserine
exposure on the cell membrane and DNA fragmentation. Cells
were labeled with fluorescein isothiocyanate-conjugated
annexin V and propidium iodide (PI) in binding buffer
(Biovision Inc., Mountain View, CA), and analyzed using
FACSCalibur  with CellQuest  software (BD Biosciences).
On the other hand, cells were incubated with 500 mgm l
 1
proteinase K (Sigma-Aldrich, St Louis, MO), 500 mgm l
 1
RNase (Sigma-Aldrich), and 1% SDS at 37 C for 30 min.
Total DNA was extracted from these cultures using a DNA
extraction kit (Wako Pure Chemical Industries Ltd, Osaka,
Japan). DNA samples were electrophoresed in 1.5% agarose
gels and visualized by ethidium bromide staining.
Cell Cycle
Cells were fixed with 70% ethanol (Wako) at 4 C for 2 h.
After washing and centrifugation, the precipitates were
84 Antiproliferative effects of Agaricus blazeiresuspended in 50 mgm l
 1 PI solution including 250 mgm l
 1
RNase, and incubated at 37 C for 30 min. DNA content
in the cells was determined using FACSCalibur  with
CellQuest  software. In cell cycle analyses, the signals
of aggregating cells were removed on an FL-width/FL-
area dot plot. In one experiment, CCRF-CEM cells were
enriched at early S, mid-S or G2/M and G1 phases of the
cell cycle with a high concentration of thymidine as descri-
bed previously (18). Briefly, the cells were cultured in the
presence of 2 mM thymidine (Sigma-Aldrich) for 24 h, and
then cultured without thymidine for 12 h. The cells were
further incubated with 2 mM thymidine for 14 h, followed by a
4, 10 or 16 h recovery period without thymidine for cell
enrichment at early S, mid-S or G2/M and G1 phases,
respectively.
Caspase Activity
Aliquots of cells (5 · 10
5) were stained with a
carboxyfluorescein-labeled fluoromethyl ketone peptide
(FAM-LEHD-FMK; Chemicon International Inc., Temecula,
CA), which permeates the cell membrane and binds covalen-
tly to active caspase-9, in culture medium at 37 C for 1 h
according to the manufacturer’s instructions. After washing
and PI staining, the caspase activity was analyzed by flow
cytometry.
Western Blotting
The cytosolic protein fraction was prepared as described
previously (19). Briefly, cells were suspended in extraction
solution (20 mM HEPES, pH 7.5, 10 mM KCl, 1.9 mM MgCl2,
1 mM EDTA, 1 mM EGTA) containing protease inhibitor
cocktail (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and
incubated on ice for 20 min. The homogenate was centrifuged
at 1000· g for 5 min to pellet out nuclei and intact cells. The
supernatant was further centrifuged at 14000· g for 30 min to
collect the cytosolic (supernatant) fraction. Aliquots of 30 mg
of the protein were separated by SDS–PAGE and transferred
onto PVDF membranes. The membranes were blocked with
5% non-fat dry milk in Tris-buffered saline, and then
incubated with 0.2 mgm l
 1 anti-cytochrome c antibody. Blots
were developed with horseradish peroxidase-conjugated
secondary antibody, and proteins were visualized by enhan-
ced chemiluminescence staining (Amersham Biosciences,
Piscataway, NJ).
p38 MAPK Activation
Phosphorylated p38 MAPK in individual cells was detected by
flow cytometric analysis for intracellular staining according to
the manufacturer’s protocol (Cell Signaling Technology Inc.;
http://www.cellsignal.com/support/protocols/). Briefly, cells
were suspended in PBS, and fixed with methanol-free
formaldehyde (Polysciences Inc., Warrington, PA) at a final
concentration of 2% for 10 min at 37 C. The cells were then
permeabilized by adding ice-cold 100% methanol while gently
vortexing so that final concentration was 90% methanol,
followed by incubation on ice for 30 min. After washing,
aliquots of the cells were incubated in PBS containing 0.5%
BSA for 10 min and then rabbit anti-phospho-p38 MAPK mAb
was added. After a further 30 min incubation and washing, the
cells were reacted with fluorescein isothiocyanate-conjugated
anti-rabbit IgG (Jackson ImmunoResearch Laboratories Inc.,
West Grove, PA) for 30 min. After washing, the cells were
analyzed by flow cytometry.
Results and Discussion
The Influence of ABH on Cell Proliferation Differed
Between Cell Lines
Five human leukocytic cell lines were cultured with graduated
concentrations of ABH, aqueous extract of A. blazei or
aqueous extract of A. blazei containing 0.1% inactivated
hemicellulases. After a 3 day incubation, cell proliferation
was examined using tetrazolium salt and expressed relative
to cell growth in culture medium only (Fig. 1). Although
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Figure 1. Hemicellulase-degradation enhanced the antiproliferative effect of A. blazei on some cell lines. Five leukocytic cell lines were cultured with the
indicated concentrations of ABH (A), aqueous extract of A. blazei (B) or aqueous extract of A. blazei containing inactivated hemicellulases (C). Tetrazolium salt
was added to the cultures after 3 days, and optical density was read. Percent proliferation indicates the proportion relative to cell growth in culture medium only.
Data are representative of two separate experiments with similar results. Jurkat (plus), BALL-1 (cross), CCRF-CEM (closed diamond), U937 (closed square) and
THP-1 (open circle).
eCAM 2007;(4)1 85aqueous extract of A. blazei showed an antiproliferative
effect on Jurkat and BALL-1 cells, this substance had no
effect on the cell growth of CCRF-CEM, U937 or THP-1 cells
(Fig. 1B). However, hemicellulase-degradation of A. blazei
not only enhanced its antiproliferative effect on Jurkat and
BALL-1 cells, but also generated an effect on growth of the
other cell lines (Fig. 1A). Jurkat and BALL-1 cells were
more susceptible to ABH than the other cell lines examined;
ABH inhibited their proliferation in a dose-dependent manner,
and influenced their growth even at a relatively low concen-
tration (0.003%). In addition, ABH strongly suppressed the
growth of CCRF-CEM and U937 cells at a high concentration
(0.1%). However, THP-1 cells responded poorly to ABH even
at a high concentration (0.1%). On the other hand, addition of
the same amount of inactivated hemicellulases to aqueous
extract of A. blazei did not show such enhanced effects
(Fig. 1C). Next, as the assay using tetrazolium salt does
not discriminate between cell growth inhibition and cell
injury, the viable cell number and viability of these cells,
which were cultured with 0.1% ABH, were assessed every
day by the trypan blue dye exclusion method (Fig. 2A).
These cell lines showed different reactions to ABH. ABH
produced severe injury to Jurkat and BALL-1 cells on Day
2 or later in culture, and resulted in a decrease in the
number of viable cells over time. However, ABH showed
little cytotoxicity against CCRF-CEM or U937 cells, although
it strongly inhibited their proliferation. In contrast, ABH
had no effect on proliferation of THP-1 cells, as also shown
in the assay using tetrazolium salt. In addition, no inhibition
of proliferation was observed in three adherent cell lines
(HeLa, HMV-1 and MCF7 cells), which were cultured in the
presence of 0.1% ABH (Fig. 2B). ABH caused damage to
some cell lines, inhibited proliferation of different cell lines
without severe cytotoxicity or had no effect on growth of
others. On the other hand, the same concentration of
aqueous extract of A. blazei showed an antiproliferative
effect but little cytotoxic effect on Jurkat and BALL-1 cells
(data not shown). These results indicated that hemicellulase-
degradation resulted in qualitative and/or quantitative
changes in the nature of the effect of A. blazei on cell
proliferation.
ABH Induced Apoptosis and Delay of Cell Cycle
Progression in Responsive Cell Lines
To investigate the effects of ABH in more detail, we exa-
mined whether ABH caused apoptosis in these cells. Five
leukocytic cell lines were cultured in the presence of 0.1%
ABH for 3 days as described above. FACS analyses showed
populations of annexin V-stained cells with different
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Figure 2. ABH had different effects on growth of several cell lines. The cells were cultured in the presence (closed circle) or absence (open circle) of 0.1%
ABH for the indicated times (days). (A) The viable cell number (top) was assessed by the trypan blue dye exclusion method, and the viability (bottom)
was determined as the percentage of trypan blue-negative cells to total cells. Data are representative of two separate experiments with similar results.
(B) The proliferation of adherent cell lines was expressed as OD after addition of tetrazolium salt. Data are representative of two separate experiments with similar
results.
86 Antiproliferative effects of Agaricus blazeistaining properties of PI in ABH-treated Jurkat and BALL-1
cells (Fig. 3A). On the other hand, these populations were
detectable but were markedly smaller in CCRF-CEM and
U937 cells cultured with 0.1% ABH, which had a significant
antiproliferative effect on these two cell lines. In addition,
ABH did not induce apoptosis in THP-1 cells under the
same conditions. Another characteristic feature of apoptosis,
DNA fragmentation, which is detected as DNA ladder
formation by electrophoretic separation on agarose gels, was
also observed in ABH-treated BALL-1 cells (Fig. 3B, lane 3).
However, fragments of apoptotic DNA were not detectable in
ABH-treated CCRF-CEM cells (lane 5) in this assay, as was
the case with ABH-treated THP-1 (lane 7) and all untreated
cells (lanes 2, 4 and 6). These results indicated that ABH
induced apoptosis in some cell lines, but that it also had other
effects on cell growth, because it strongly suppressed the
proliferation of CCRF-CEM and U937 cells without severe
cytotoxic effects. Consequently, we postulated that ABH
exerted an influence on cell cycle progression. To confirm this,
five leukocytic cell lines, which were cultured with ABH as in
the above assay, were fixed every 12 h and stained for DNA
with PI. FACS analyses demonstrated the cycle phases of
individual cells, allowing the measurement of the DNA
contents of the cells (Fig. 4). ABH induced alterations in the
distribution of cell cycle phases in four cell lines (Jurkat,
BALL-1, CCRF-CEM and U937) during incubation. Their
dominant peaks on histograms shifted from G1 to early S phase
in the first 24 h. The majority or a portion of these cells moved
synchronously in S phase during the next 12 h. On the other
hand, the distribution pattern of cell cycle phases of ABH-
treated THP-1 remained virtually constant throughout the
experimental period, as was the case with all untreated cell
lines (data not shown). Although the receptivity of these cell
lines to ABH in alteration of cell cycle progression corre-
sponded to that in cell proliferation, these results raised an
additional question of whether this alteration resulted in
inhibition of cell proliferation. Therefore, CCRF-CEM cells
were pre-treated with a high concentration of thymidine,
followed by different recovery periods without thymidine to
enrich the cellsin early S, mid-S or G2/M and G1phases. These
cells were then left untreated or were cultured with ABH as
before (Fig. 5). The cells in early S phase at the onset (0 h)
progressed synchronously in this phase during the first 6 h
without ABH, and the bulk of the cells entered G2/M phase
within 12 h, and formed a dominant peak of G1 phase, as seen
on the histogram at 18 h (Fig. 5A, top). However, the cells in
early S phase at the onset moved more slowly in this phase in
culture with ABH, and almost all cells were still in S and G2/M
phases even after 30 h (Fig. 5A, bottom). Similarly, the cell
cycle progression of cells in mid-S phase at the onset was
Figure 3. ABH induced apoptosis in some cell lines. (A) Apoptosis was assessed by phosphatidylserine exposure on the cell membrane. The cells were cultured in
the presence or absence of 0.1% ABH for 3 days, and stained with fluorescein isothiocyanate-conjugated annexin V and PI. The numbers in dot plots indicate the
percentage of the total cell number in each quadrant. Data are representative of three separate experiments with similar results. (B) Apoptosis was also assessed by
determination of DNA fragmentation. BALL-1, CCRF-CEM and THP-1 cells were cultured in the presence (lanes 3, 5 and 7) or absence (lanes 2, 4 and 6) of 0.1%
ABH. Total DNA was extracted from the cells, subjected to agarose gel electrophoresis and stained with ethidium bromide. Data are representative of two separate
experiments with similar results.
eCAM 2007;(4)1 87markedly delayed in cultures to which ABH was added, and
the cells did not form a dominant peak of G1 phase even after
24 h unlike those cultured without ABH (Fig. 5B). In contrast,
the cells in G2/M phase at the onset made a transition to G1
phase even in the presence of ABH to the same extent as those
cultured without ABH, and then the G1 peak formed by these
cells shifted to early S phase (Fig. 5C). These results suggested
that ABH delayed cell cycle progression in S phase resulting in
concentration of the cells in this phase. The inhibition of cell
proliferation was induced, at least in part, by exposure to ABH
in S phase and subsequent delay of cell cycle progression in
responsive cells.
Mitochondria Played a Role in Apoptosis
Induced by ABH
A recent study demonstrated that b-glucan extracted from
A. blazei induced mitochondria-mediated apoptosis in a human
ovarian HRA cell line (15). Therefore, we examined release of
mitochondrial cytochrome c into the cytosol, which is one of
Figure 4. ABH induced S phase-synchronization of cell cycle progression in responsive cell lines. The cells were cultured with 0.1% ABH for the indicated times
(hours), followed by fixation and staining for DNA. FACS analyses were used to determine the DNA contents of individual cells.
Figure 5. ABH induced a delay of cell cycle progression in S phase. CCRF-CEM cells were enriched in early S (A), mid-S (B)o rG 2/M and G1 (C) phases
in advance, and then cultured in the presence or absence of 0.1% ABH for the indicated times (hours), followed by fixation and staining for DNA. FACS analyses
were used to determine the DNA contents of individual cells. NT indicates that the cells were not treated with thymidine and ABH. Data are representative of
two separate experiments with similar results.
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(20), in cultures with ABH. BALL-1, CCRF-CEM and THP-
1 cells, which were differentially sensitive to ABH, were
cultured with 0.1% ABH, and the cytosolic fraction was
prepared every 24 h. Western blotting analysis indicated that
ABH treatment induced release of cytochrome c into the
cytosol in a time-dependent manner in BALL-1 cells (Fig. 6A).
The release of cytochrome c was slight in the first 24 h, but it
increased to a large extent subsequently. On the other hand,
ABH-treated CCRF-CEM cells showed the minimal release at
a later stage in culture, and no release of cytochrome c was
observed in ABH-treated THP-1 cells throughout the experi-
mental period. Next, these cells were stained with PI and a
fluorescent-conjugated peptide (FAM-LEHD-FMK), which
binds active caspase-9, as the release of mitochondrial
cytochrome c leads to activation of caspase-9, followed by
activation of caspase-3, which initiates a set of events that
culminate in apoptosis (21). FACS analyses detected larger
populations of caspase-9-active BALL-1 cells in culture with
ABH for 3 days (Fig. 6B) but not 1 day (data not shown). As
expected, the degrees of caspase-9 activation corresponded to
those of release of cytochrome c in ABH-treated CCRF-CEM
and THP-1 cells.
p38 MAPK Activation was Responsible for
ABH-Induced Effects
The study by Kobayashi et al. cited above also indicated that
b-glucan extracted from A. blazei induced activation of p38
MAPK in HRA cells, and that p38 MAPK-specific inhibitor
suppressed b-glucan-induced apoptosis (15). p38 MAPK has
been shown to respond strongly to various stress stimuli, such
as osmotic shock, lipopolysaccharide, inflammatory cytokines
and irradiation (22–24), and studies using the inhibitor
suggested that p38 activation is responsible for apoptosis
induced by these stressors (25). Therefore, we also analyzed
p38 activation after treatment with ABH in five leukocytic cell
lines. These cells were incubated with 0.1% ABH for up to
64 h. The permeabilized cells were reacted with anti-phospho-
p38 MAPK mAb, and the levels of phosphorylated p38 MAPK
were measured by flow cytometry (Fig. 7). ABH induced
strong p38 activation, which peaked within 15 min and
returned to the basal levels in 60 min in both Jurkat and
BALL-1 cells. On the other hand, ABH also activated p38
MAPK in CCRF-CEM and U937 cells, although the levels
were very much lower than in Jurkat and BALL-1 cells.
CCRF-CEM cells showed extremely weak and slow p38
activation in response to ABH, peaking at 16 h. However,
these four cell lines showed p38 activation even after 64 h in
culture. In contrast, ABH-treated THP-1 cells showed no p38
activation up to 64 h in culture. Next, we examined whether
MEK and MAPK inhibitors attenuated the ABH-induced
effects on cell growth. Four cell lines responsive to ABH were
pre-treated with 10 mM SB203580, a p38 MAPK-specific
inhibitor, 4 mM SP600125, a JNK-specific inhibitor or 10 mM
PD98059, a MEK-specific inhibitor, and then cultured with or
without 0.1% ABH for 3 days. Their cell proliferation was
examined using tetrazolium salt as described above, and
Figure 6. The mitochondria-mediated pathway participated in apoptosis induced by ABH. BALL-1, CCRF-CEM and THP-1 cells were cultured with 0.1% ABH.
(A) The cytosolic fraction was prepared every 24 h, and subjected to western blotting analysis with anti-cytochrome c antibody. (B) These cells, which were
cultured in the presence or absence of 0.1% ABH for 3 days, were stained with PI and a fluorescent-conjugated peptide specific for active caspase-9. The numbers
in dot plots indicate the percentage of the total cell number in each quadrant.
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(Fig. 8A). These concentrations of inhibitors had no effect
on growth of the four cell lines by themselves (data not
shown). However, SB203580 weakened the antiproliferative
effects of ABH on all of these cell lines, blocking the
antiproliferative effects in CCFR-CEM and U937 cells almost
completely. On the other hand, SP600125 and PD98059 had
almost no influence on the ABH-induced effects, or rather
increased the effect slightly, except in U937 cells. Increased
concentrations of these two inhibitors (up to 50 mM) also
did not improve the proliferation of ABH-treated cells
(data not shown). FACS analyses confirmed that pre-treatment
with SB203580 moderately or significantly inhibited ABH-
induced apoptosis in Jurkat or BALL-1 cells, respectively
(Fig. 8B). It was interesting to note that SB203580 also
markedly improved the ABH-induced delay of cell cycle
progression in S phase to almost the same degree as in cultures
without ABH in CCRF-CEM cells, which had been syn-
chronized in S phase at the onset of the experiment (Fig. 8C).
These results indicated that ABH induced continual p38
activation, the levels of which differed between cell lines, and
that this p38 activation was involved in not only apoptosis but
also in the delay of cell cycle progression in S phase induced
by ABH.
The Combination of ABH and TNF-a Induced
Continual Strong Activation of p38MAPK andResulted
in Apoptosis in CCRF-CEM and U937 Cells
ABH showed a weak cytotoxic effect in CCRF-CEM and
U937 cells despite its strong antiproliferative effect (Fig. 2A).
It induced low levels of p38 activation in CCRF-CEM and
U937 cells unlike BALL-1 and Jurkat cells, in which high
levels of p38 activation resulted in both alteration of cell cycle
progression and apoptosis. Therefore, we hypothesized that
weak p38 activation by ABH did not result in apoptosis.
However, we also suspected that these two cell lines were not
susceptible to apoptosis regardless of the degree of p38
activation. Consequently, we attempted to increase the activity
of p38 MAPK in these two cell lines. TNF-a has a wide variety
of physiological activities. The ligation of TNF-a and its
receptor on the cells has been shown to induce p38 activation
(23). In addition, it has been shown that TNF-a triggers death
receptor-mediated apoptosis (26). However, it also has anti-
apoptotic effects, activating NF-kB (27). In fact, TNF-a
(10 nM) had only a minor impact on growth of CCRF-CEM
and U937 cells by itself (Fig. 9A). FACS analyses also showed
that TNF-a induced little apoptosis in these two cell lines
(Fig. 9B). However, the combination of 0.1% ABH and 10 nM
TNF-a significantly augmented the cytotoxic effects on
these cell lines. This combination decreased the cell viability
of the cultures to far lower levels (Fig. 9A), and generated
larger populations of annexin V-stained cells (Fig. 9B).
Furthermore, the combination of ABH and TNF-a signifi-
cantly augmented the activation of caspase-9 in CCRF-CEM
cells (Fig. 9C), although TNF-a alone had little effect on the
activation of caspase-9 in CCRF-CEM cells, and ABH also
hardly activated caspase-9 in these cells (Fig.6B).On the other
hand, the growth of THP-1 cells was unaffected even by the
same combination of ABH and TNF-a. Based on these results,
the levels of p38 activation were measured in cultures with
ABH and TNF-a (Fig. 10A). TNF-a induced sufficient levels
Figure 7. ABH induced different degrees of p38 activation. After the cells were fixed and permeabilized, the levels of phosphorylated p38 MAPK in the cells,
which were exposed to 0.1% ABH for the indicated times, was measured by flow cytometry.
90 Antiproliferative effects of Agaricus blazeiof p38 MAPK activation immediately in these two cell lines,
although it induced little apoptosis. On the other hand, p38
activation induced by combination of ABH and TNF-a was
far stronger and longer lasting. These two cell lines showed
a transient decrease in p38 MAPK activity after the rapid
and strong activation, but the cells then showed restoration of
the extremely strong activation at 16 and 64 h. Next, we
examined whether this p38 activation was correlated with the
enhanced cytotoxicity induced by combination of ABH and
TNF-a. SB203580 significantly attenuated the enhanced
cytotoxic effect on CCRF-CEM and U937 cells cultured
with ABH and TNF-a (Fig. 10B). FACS analyses also
confirmed that it blocked apoptosis induced by ABH and
TNF-a (Fig. 10C). Although this enhancement of the cytotoxic
effect was not due to upregulation of TNF type 1 receptor
(TNFR1) on the cells by ABH (data not shown), the
mechanism remains to be elucidated in detail. However,
these results suggested that the degrees of p38 activation
induced by ABH, which were dependent on tumor cells and
other stimuli, determined subsequent cellular responses on cell
growth. We envisaged that some cell factors defined the
responsiveness of p38 MAPK to ABH. Many molecules, such
as TNF receptor family and Toll like receptors (28,29), protein
kinase C (PKC) subtypes (30) and small G proteins (31), have
been suggested to play a role in p38 activation. The
quantitative or functional differences in these molecules
between cell lines may result in differences in responsiveness
to ABH. ABH is a crude extract from A. blazei mycelia and
consists of multiple components. The components responsible
for the ABH-induced effects demonstrated in the present study
have not yet been identified. However, as hemicellulase-
degradation of A. blazei enhanced the inhibitory effects on cell
proliferation, some low molecular weight carbohydrate
components may be involved in these effects, acting on the
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Figure 8. p38 activation was responsible for the effects of ABH. (A) The cells were pre-treated with 10 mM SB203580 (SB), 4 mM SP600125 (SP), 10 mM
PD98059 (PD) or 0.3% DMSO, which was used for dissolution of these MEK and MAPK inhibitors, for 30 min, and cultured in the presence or absence of 0.1%
ABH. Tetrazolium salt was added to the cultures after 3 days. Percent proliferation indicates the proportion relative to cell growth without ABH. Data are shown as
means ± SD of duplicate cultures. Data are representative of two separate experiments with similar results. (B) Jurkat and BALL-1 cells were pre-treated with
SB203580 (SB) or DMSO as described above, and cultured with 0.1% ABH for 3 days. The cells were stained with fluorescein isothiocyanate-conjugated annexin
Vand PI.The numbersin dotplots indicatethe percentage of thetotal cell numberin each quadrant.(C) CCRF-CEMcells wereenrichedin S phasein advance.The
cells were pre-treated with SB203580 (SB) as described above, and cultured in the presence or absence of 0.1% ABH for the indicated times (hours), followed by
fixation and staining for DNA. NT indicates that the cells were not treated with thymidine and ABH. Data are representative of two separate experiments with
similar results.
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not yet been clarified.
Physiological Significance of ABH on the Antitumor
Effects of Existing Treatments
Many patients with cancer in Japan have consumed A. blazei in
the belief that it has medicinal properties. However, there is
little evidence of its effectiveness against cancer in humans
(32). It has been suggested that A. blazei improves immuno-
logical status, as demonstrated in animal experiments. Some
recent studies indicated that A. blazei also has inhibitory
effects on tumor cell growth, tumor-induced neovasculariza-
tion, and cancer metastasis. In the present study, ABH induced
inhibition of cell proliferation in some cell lines. However, our
results showed that ABH does not have an antiproliferative
effect on all tumor cells, and this suggested the limitation of its
efficacy against cancer. Moreover, as ABH induced a delay in
cell cycle progression in S phase in some tumor cells, it may
also have an influence on the benefits of existing therapeutic
regimens against cancer. For example, this feature of ABH
may put patients at a disadvantage regarding the efficacy
of radiation therapy for cancer. In general, it has been
demonstrated that tumor cells are more susceptible to
irradiation in M phase and at the boundary of G1/S of the cell
cycle, whereas they can show resistance during the last half of
S phase (33). Thus, the enrichment of tumor cells in S phase by
ABH may cause attenuation of the effectiveness of radio-
therapy. In contrast, tumor cells richer in S phase yield better
effects of therapeutic heating and drugs that act specifically in
S phase, such as antimetabolites. The synchronous delay of
tumor cells in S phase by ABH may enable a number of cells to
be exposed to the drugs in S phase for a long time. In addition,
this may result in a decrease in time and frequency of
administration of the drugs.
In conclusion, we examined the effects of ABH on prolifer-
ation of several tumor cell lines. ABH induced p38 MAPK-
mediated delay of cell cycle progression and apoptosis in some
cell lines. The growth of other cell lines showed poor or no
responses to ABH. We hypothesized that the reactivity of cell
growth to ABH was dependent on some cellular factor(s),
which regulate p38 MAPK activation in response to ABH.
These observations also indicate that the use of ABH as a
complementary and alternative medicine is not necessarily
appropriateforalltumors.Theelucidationofthesecellularfac-
tors in future studies will facilitate the appropriate use of ABH.
Figure 9. The combination of ABH and TNF-a increased susceptibility to apoptosis. CCRF-CEM, U937 and THP-1cells were cultured with 10 ng ml
 1 TNF-a in
the presence or absence of 0.1% ABH. (A) Cell viability was assessed by the trypan blue dye exclusion method at the indicated times (open circle, without ABH;
closed circle, with ABH). Data are representative of two separate experiments with similar results. (B) The cells were stained with fluorescein isothiocyanate-
conjugated annexin V and PI on day 3. (C) CCRF-CEM cells were also stained with a fluorescent-conjugated peptide specific for active caspase-9 and PI on Day 3.
The numbers in dot plots indicate the percentage of the total cell number in each quadrant.
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